Загрузка...
Naltrexone for impulse control disorders in Parkinson disease: A placebo-controlled study
OBJECTIVE: Impulse control disorders (ICDs) in Parkinson disease (PD) are common and can be difficult to manage. The objective of this study was to determine the efficacy and tolerability of naltrexone, an opioid antagonist, for the treatment of ICDs in PD. METHODS: Patients with PD (n = 50) and an...
Сохранить в:
| Главные авторы: | , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Lippincott Williams & Wilkins
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4155050/ https://ncbi.nlm.nih.gov/pubmed/25037206 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000000729 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|